Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- ACARIX.ST
- Price
- 0.28
- Stock movement down
- -0.00 (-1.05%)
- Company name
- Acarix A/S
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Markkapitalisasie
- 299.97M
- Ondernemingswaarde
- 265.28M
- Prys/Verkope
- 52.84
- Prys/Boek
- 4.68
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- -
- PEG
- -
- EPS groei
- -29.00%
- 1 jaar opbrengs
- 58.78%
- 3 jaar opbrengs
- -26.29%
- 5 jaar opbrengs
- -21.18%
- 10 jaar opbrengs
- -
Laaste opgedateer: 2024-12-21
DIVIDENDE
ACARIX.ST betaal nie dividende nie of geen data is ontvang nie
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | 52.84 |
| Prys tot Boekwaarde | 4.68 |
| EV tot verkope | 46.73 |
FINANSIËLE
Per aandeel
Loading...
Per aandeel gegewens
| Huidige aandeeltelling | 1.06B |
| EPS (TTM) | -0.07 |
| FCF per aandeel (TTM) | -0.07 |
Inkomstestaat
Loading...
Inkomstestaat gegewens
| Inkomste (TTM) | 5.68M |
| Bruto wins (TTM) | 5.13M |
| Bedryfsinkomste (TTM) | -72.06M |
| Netto inkomste (TTM) | -72.23M |
| EPS (TTM) | -0.07 |
| EPS (1j vorentoe) | - |
Marges
Loading...
Marges gegewens
| Bruto marge (TTM) | 90.31% |
| Bedryfsmarge (TTM) | -1269.28% |
| Winsgrens (TTM) | -1272.31% |
Balansstaat
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
| Kontant | 44.18M |
| Netto debiteure | 3.40M |
| Totale bedryfsbates | 62.79M |
| Klandisiewaarde | 0.00 |
| Ontasbare bates | 10.25M |
| Eiendom, aanleg en toerusting | 510.00K |
| Totale bates | 73.55M |
| Rekeninge betaalbaar | 5.12M |
| Kort/huidige langtermynskuld | 0.00 |
| Totale bedryfslaste | 9.49M |
| Totale laste | 9.49M |
| Aandeelhouersbelang | 64.06M |
| Netto tasbare bates | 0.00 |
Kontantvloei
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
| Bedryfskontantvloei (TTM) | -69.49M |
| Kapitale uitgawes (TTM) | 741.00K |
| Vrye kontantvloei (TTM) | -70.23M |
| Dividende betaal (TTM) | 0.00 |
Finansiële opbrengste
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
| Opbrengs op ekwiteit | -112.75% |
| Opbrengs op bates | -98.20% |
| Opbrengs op belegde kapitaal | -112.75% |
| Kontant opbrengs op belegde kapitaal | -109.63% |
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 0.28 |
| Daaglikse hoog | 0.29 |
| Daaglikse laag | 0.28 |
| Daaglikse volume | 2.88M |
| Hoogtepunt van alle tye | 8.29 |
| 1j analiseraaming | 0.45 |
| Beta | 1.48 |
| EPS (TTM) | -0.07 |
| Dividend per aandeel | - |
| Ex-dividend datum | - |
| Volgende verdienste datum | 13 Feb 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| ACARIX.ST | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -96.60% | -2.74% |
| Hoogste prysdaling | -97.86% | -56.47% |
| Datum van hoogste daling | 21 Dec 2023 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -78.93% | -11.13% |
| Gemiddelde tyd tot nuwe hoogtepunt | 404 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 2017 days | 1805 days |
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
299.97M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Werknemers
14
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
Sweden
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has decided that the CPT code 0716T - the CADScor® Sy...
4 November 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-b...
22 Augustus 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces expanded use of the CADScor System within wellness exams as part of self-insured companies' health plans. As healthcare ...
12 Augustus 2024
VANCOUVER, BC / ACCESSWIRE / July 30, 2024 / Acarix CEO Aamir Mahmood joined Steve Darling from Proactive to share news the company has begun trading on the OTCQB Market in the United States, under th...
30 Julie 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today on the OTCQB Market in the US. Acarix´s shares wi...
15 Julie 2024
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to collect real-world data to compare workflows between traditional stres...
11 April 2024
Acarix, a leader in acoustic-based Cardiac Diagnostics, is pleased to announce the results from a 2024 American College of Cardiology (ACC) poster presentation by Suzanne Baron, MD, MSc, Director of I...
8 April 2024
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team. Joining the advisory board are Ken Nelson, known for his leadership in the...
15 Februarie 2024
Acarix, a leader in advanced acoustic-based cardiac diagnostic devices today announces the CADScor® System has been added to the United States Federal Supply Schedule (FSS). The nationwide contract si...
5 Februarie 2024